ABT

SELL

Abbott Laboratories

Healthcare · Rank #263 · Analyzed Oct 18, 2026

$104.89

Current Price

$65.05

Intrinsic Value

-38.0%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 38.0%

Fair Value Range

Low$10.73

Base (IV)$65.05

High$83.49

Entry Points

Conservative$7.51

Moderate$10.73

Aggressive$45.53

Quality & Moat Breakdown

Return on Equity10.6% → 0.5/1.0

Debt LevelD/E 63 → 0/1.0

Revenue QualityGrowth 3.0%, margin Δ+6.0% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins11.6% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.